Authors
Latest:
Advice on choosing AREDS or AREDS 2 in non-smokersIn this article, the authors discuss the benefits of nutritional supplementation in preventing AMD progression and consider which AREDS formulation is the most appropriate in smokers and non-smokers.
Latest:
Lasting effects of anti-VEGF/photodynamic therapy for AMDThe authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.
Latest:
Real-world experience: Case study shows maintained benefits with FAc in DME patientIn the case study discussed in this article, a patient who was treated for DME with a fluocinolone acetonide intravitreal implant reported improved vision-related quality of life and the ability to perform daily routines without problems. These benefits persisted 12-months after treatment.
Latest:
Lasting effects of anti-VEGF/photodynamic therapy for AMDThe authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.
Latest:
Real-world experience: Positive DME treatment outcomes observed with FAc implant at UK centreDr Mushtaq discusses one centre’s initial post-marketing experience with the fluocinolone acetonide intravitreal implant 0.19 mg. The implant demonstrated favourable outcomes and good patient acceptance.
Latest:
Lasting effects of anti-VEGF/photodynamic therapy for AMDThe authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.
Latest:
Lasting effects of anti-VEGF/photodynamic therapy for AMDThe authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.
Latest:
New refractive technologies: early experiences, thoughtsShortcomings in ablative procedures mean that new developments in refractive surgery are welcome. Arthur Cummings, MD, FRCSEd, reviews two new technologies that will increase patient satisfaction.
Latest:
Filtration device lowers IOP in patients with PEG and POAGA glaucoma filtration device was equally effective in reducing IOP in pseudoexfoliative glaucoma and primary open-angle glaucoma patients, in a recent small study.
Latest:
MIGS stent yields good IOP control as stand-alone treatmentMicrostent implantation had favorable and safe results in a group of patients with open-angle glaucoma in the DUETTE trial.
Latest:
Mobile EHR photos brings instant visualization of clinical imagesCapturing clinical images with the integration of electronic health records and smartphone applications can enhance practice efficiency and compliance.
Latest:
Mobile EHR photos brings instant visualization of clinical imagesCapturing clinical images with the integration of electronic health records and smartphone applications can enhance practice efficiency and compliance.
Latest:
Therapeutic advances in glaucoma focus on retinal ganglion cell pathologyFindings from basic science research elucidating the mechanisms of retinal ganglion cell axon degeneration, regeneration, and death have identified new therapeutic targets for glaucoma that are being investigated in preclinical and clinical studies.
Latest:
Anterior capsulotomy is the main prostaglandin release inducer in FLACSResearch presented in this article found anterior capsulotomy to be the main trigger for an increase of prostaglandins in aqueous humor immediately after laser-assisted cataract surgery. Optimised energy settings in combination with NSAIDs might therefore help reduce laser-induced miosis.
Latest:
Bladeless, custom FLACS technology: What's in a name?A small review recently found 28 different names for the procedure, and the chances are there are even more currently in use.
Latest:
Are you reaching the right audience? Identifying when change is necessaryThe title of this blog may have you answering in the affirmative -after all, working in medicine is all about the patients, right?
Latest:
6 things PCPs should know about glaucomaGlaucoma is a leading cause of blindness, a problem which is made even more serious by the fact that many patients do not notice any symptoms until it is too late to prevent permanent blindness.
Latest:
Pupil expander manages unique needs of small pupilsA pupil expansion device is flexible, yet stable and can easily be inserted and removed for cataract surgery procedures.
Latest:
Anti-VEGF patterns of use for DME may vary in clinical practiceThough anti-vascular endothelial growth factor therapy for diabetic macular edema showed impressive results in trials, clinicians have reported less success on their own.
Latest:
Research Scholar Honoree Program draws global interest amid pandemicFellows, residents from around the world show promise for future of retinal research.
Latest:
Key strategies for treating postsurgical CMECystoid macular edema can permanently alter vision, so it is highly crucial to utilize best practices for treating the cataract surgery complication.
Latest:
Technologic advances integrate OCT into real-time surgeriesResearchers are conducting a prospective, multisurgeon, single-center study to evaluate multiple microscope integrated-prototypes with real-time surgeon feedback.
Latest:
New wide-field, dual-array, suprachoroidal-transretinal stimulation prosthesis demonstrates surgical feasibilityProf. Fujikado presents his research, which demonstrated the surgical feasibility and safety of a newly developed, dual-array, suprachoroidal-transretinal stimulation prosthesis in animals. The dual-array design was able to activate retinal neurons and optic nerve axons. Findings indicate the future possibility of activating of a larger visual field with the prosthesis.
Latest:
New wide-field, dual-array, suprachoroidal-transretinal stimulation prosthesis demonstrates surgical feasibilityProf. Fujikado presents his research, which demonstrated the surgical feasibility and safety of a newly developed, dual-array, suprachoroidal-transretinal stimulation prosthesis in animals. The dual-array design was able to activate retinal neurons and optic nerve axons. Findings indicate the future possibility of activating of a larger visual field with the prosthesis.
Latest:
Looking ahead: 2024 shaping up to be an interesting yearJoshua Mali, MD, offers up his predictions for ophthalmology in 2024.
Latest:
Refractive surgery for special needs children: The time is nowThe time for refractive surgery for special needs children seems to be at hand, considering that advancements in laser and IOL technologies have been proven to be efficacious. Correcting a special needs child’s vision can reduce fearfulness and improve their behavioral challenges.
Latest:
Acute nonarteritic CRAO: A red flag for cardiovascular risk factorsMost patients with acute nonarteritic central retinal artery occlusion have a cardiovascular risk profile, and a comprehensive medical evaluation can uncover more risk factors.
Latest:
Photostimulation promising for central serous chorioretinopathyA pilot study suggests that using subthreshold photostimulation with a 577-nm PASCAL yellow laser is an effective and safe option for central serous chorioretinopathy.
Latest:
Functional imaging of ocular circulation under developmentFunctional optical coherence tomography characterizing global and local circulation in the retina and optic nerve head shows promise for improving the diagnostic and prognostic evaluation of glaucoma.
